Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
6.24
-0.47 (-7.00%)
Apr 3, 2025, 4:00 PM EDT - Market closed
Immunome Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Cash & Equivalents | 143.35 | 98.68 | 20.32 | 49.23 | 39.77 | Upgrade
|
Short-Term Investments | 73.95 | 39.46 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 217.3 | 138.14 | 20.32 | 49.23 | 39.77 | Upgrade
|
Cash Growth | 57.30% | 579.73% | -58.72% | 23.80% | 1463.74% | Upgrade
|
Accounts Receivable | - | - | - | 1.64 | - | Upgrade
|
Other Receivables | - | - | 0.85 | 2.67 | 0.85 | Upgrade
|
Receivables | - | - | 0.85 | 4.31 | 0.85 | Upgrade
|
Prepaid Expenses | 4.04 | 6.56 | 1.03 | 2.51 | 2.28 | Upgrade
|
Other Current Assets | - | - | 0.45 | 0.59 | - | Upgrade
|
Total Current Assets | 221.34 | 144.7 | 22.65 | 56.64 | 42.89 | Upgrade
|
Property, Plant & Equipment | 14.39 | 3.64 | 0.97 | 0.86 | 1.53 | Upgrade
|
Long-Term Deferred Charges | - | - | 0.33 | 0.33 | - | Upgrade
|
Other Long-Term Assets | 4.51 | 0.2 | 0.1 | 0.1 | 0.1 | Upgrade
|
Total Assets | 240.24 | 148.54 | 24.05 | 57.93 | 44.53 | Upgrade
|
Accounts Payable | 14.19 | 3.31 | 2.4 | 3.08 | 1.19 | Upgrade
|
Accrued Expenses | 30.98 | 6.98 | 4.62 | 4.31 | 1.27 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 0.48 | Upgrade
|
Current Portion of Leases | 0.06 | 0.31 | 0.23 | - | - | Upgrade
|
Current Unearned Revenue | 6.94 | 10.49 | - | - | - | Upgrade
|
Other Current Liabilities | 2.14 | 0.73 | 0.09 | 2.34 | 0.1 | Upgrade
|
Total Current Liabilities | 54.31 | 21.83 | 7.33 | 9.73 | 3.04 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.13 | Upgrade
|
Long-Term Leases | 4.77 | 1.34 | 0.06 | - | - | Upgrade
|
Long-Term Unearned Revenue | - | 5.49 | - | - | - | Upgrade
|
Other Long-Term Liabilities | - | - | - | 0.01 | 0.01 | Upgrade
|
Total Liabilities | 59.08 | 28.66 | 7.39 | 9.74 | 3.18 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 696.87 | 342.66 | 132.65 | 127.29 | 95.74 | Upgrade
|
Retained Earnings | -515.77 | -222.81 | -116 | -79.11 | -54.39 | Upgrade
|
Comprehensive Income & Other | 0.06 | 0.02 | - | - | - | Upgrade
|
Total Common Equity | 181.17 | 119.88 | 16.65 | 48.19 | 41.35 | Upgrade
|
Shareholders' Equity | 181.17 | 119.88 | 16.65 | 48.19 | 41.35 | Upgrade
|
Total Liabilities & Equity | 240.24 | 148.54 | 24.05 | 57.93 | 44.53 | Upgrade
|
Total Debt | 4.83 | 1.65 | 0.29 | - | 0.61 | Upgrade
|
Net Cash (Debt) | 212.47 | 136.49 | 20.03 | 49.23 | 39.15 | Upgrade
|
Net Cash Growth | 55.67% | 581.37% | -59.31% | 25.74% | 1878.42% | Upgrade
|
Net Cash Per Share | 3.62 | 6.88 | 1.65 | 4.27 | 11.55 | Upgrade
|
Filing Date Shares Outstanding | 86.95 | 59.69 | 12.22 | 12.13 | 10.66 | Upgrade
|
Total Common Shares Outstanding | 64.46 | 43.25 | 12.13 | 12.11 | 10.63 | Upgrade
|
Working Capital | 167.03 | 122.87 | 15.32 | 46.91 | 39.86 | Upgrade
|
Book Value Per Share | 2.81 | 2.77 | 1.37 | 3.98 | 3.89 | Upgrade
|
Tangible Book Value | 181.17 | 119.88 | 16.65 | 48.19 | 41.35 | Upgrade
|
Tangible Book Value Per Share | 2.81 | 2.77 | 1.37 | 3.98 | 3.89 | Upgrade
|
Machinery | 9.93 | 5.75 | 3.94 | 3.69 | 3.62 | Upgrade
|
Construction In Progress | 3.3 | - | - | - | - | Upgrade
|
Leasehold Improvements | 1.64 | 0.23 | 0.19 | 0.19 | 0.19 | Upgrade
|
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.